Literature DB >> 27734322

Vitamin D Level Between Calcium-Phosphorus Homeostasis and Immune System: New Perspective in Osteoporosis.

Daniele Bellavia1, Viviana Costa1, Angela De Luca1, Melania Maglio2, Stefania Pagani3, Milena Fini2, Gianluca Giavaresi4.   

Abstract

Vitamin D is a key molecule in calcium and phosphate homeostasis; however, increasing evidence has recently shown that it also plays a crucial role in the immune system, both innate and adaptive. A deregulation of vitamin D levels, due also to mutations and polymorphisms in the genes of the vitamin D pathway, determines severe alterations in the homeostasis of the organism, resulting in a higher risk of onset of some diseases, including osteoporosis. This review gives an overview of the influence of vitamin D levels on the pathogenesis of osteoporosis, between bone homeostasis and immune system.

Entities:  

Keywords:  Calcium-phosphorus homeostasis; Immune system; Osteoporosis; Polymorphisms; Vitamin D

Year:  2016        PMID: 27734322     DOI: 10.1007/s11914-016-0331-2

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  16 in total

1.  Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis.

Authors:  Yukio Nakamura; Takako Suzuki; Tomohiko Yoshida; Hideshi Yamazaki; Hiroyuki Kato
Journal:  Nutrients       Date:  2017-04-26       Impact factor: 5.717

2.  Vitamin D Status and Its Association with Parathyroid Hormone Concentration in Brazilians.

Authors:  Juliana Sálvio Martins; Magda de Oliveira Palhares; Octávio Cury Mayrink Teixeira; Mariana Gontijo Ramos
Journal:  J Nutr Metab       Date:  2017-02-07

3.  Maternal vitamin D deficiency increases the risk of adverse neonatal outcomes in the Chinese population: A prospective cohort study.

Authors:  Yuanliu Wang; Honghui Li; Min Zheng; Yubi Wu; Ting Zeng; Jinjian Fu; Dingyuan Zeng
Journal:  PLoS One       Date:  2018-04-24       Impact factor: 3.240

Review 4.  Epigenetic Regulation of Skeletal Tissue Integrity and Osteoporosis Development.

Authors:  Yu-Shan Chen; Wei-Shiung Lian; Chung-Wen Kuo; Huei-Jing Ke; Shao-Yu Wang; Pei-Chen Kuo; Holger Jahr; Feng-Sheng Wang
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

5.  Prevalence and Fracture Risk of Osteoporosis in Patients with Rheumatoid Arthritis: A Multicenter Comparative Study of the FRAX and WHO Criteria.

Authors:  Sang Tae Choi; Seong-Ryul Kwon; Ju-Yang Jung; Hyoun-Ah Kim; Sung-Soo Kim; Sang Hyon Kim; Ji-Min Kim; Ji-Ho Park; Chang-Hee Suh
Journal:  J Clin Med       Date:  2018-12-02       Impact factor: 4.241

Review 6.  Perspectives on miRNAs as Epigenetic Markers in Osteoporosis and Bone Fracture Risk: A Step Forward in Personalized Diagnosis.

Authors:  Michela Bottani; Giuseppe Banfi; Giovanni Lombardi
Journal:  Front Genet       Date:  2019-10-30       Impact factor: 4.599

7.  MiR-33a Controls hMSCS Osteoblast Commitment Modulating the Yap/Taz Expression Through EGFR Signaling Regulation.

Authors:  Viviana Costa; Valeria Carina; Lavinia Raimondi; Angela De Luca; Daniele Bellavia; Alice Conigliaro; Francesca Salamanna; Riccardo Alessandro; Milena Fini; Gianluca Giavaresi
Journal:  Cells       Date:  2019-11-22       Impact factor: 6.600

Review 8.  Wnt Signaling and Biological Therapy in Rheumatoid Arthritis and Spondyloarthritis.

Authors:  Daniela Cici; Addolorata Corrado; Cinzia Rotondo; Francesco P Cantatore
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

Review 9.  Calcification of Cardiac Valves in Metabolic Bone Disease: An Updated Review of Clinical Studies.

Authors:  Paolo Carrai; Silvia Camarri; Carlo Renato Pondrelli; Stefano Gonnelli; Carla Caffarelli
Journal:  Clin Interv Aging       Date:  2020-07-09       Impact factor: 4.458

10.  Knowledge, Attitudes and Perceptions towards Vitamin D in a UK Adult Population: A Cross-Sectional Study.

Authors:  Clodagh O'Connor; Dominique Glatt; Lois White; Raquel Revuelta Iniesta
Journal:  Int J Environ Res Public Health       Date:  2018-10-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.